Loss of Raf-1 Kinase Inhibitor Protein (RKIP) promotes Epithelial Mesenchymal Transition (EMT) and correlates with aggressive phenotype in Pancreatic Ductal Adenocarcinoma (PDAC)

被引：0
|
作者：
Karamitopoulou, E. [1 ]
Zlobec, I. [1 ]
Lugli, A. [1 ]
Gloor, B. [1 ]
Perren, A. [1 ]
机构：
[1] Univ Bern, Inst Pathol, CH-3012 Bern, Switzerland
来源：
VIRCHOWS ARCHIV | 2013年 / 463卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：139 / 139
页数：1
相关论文
共 18 条
  • [1] Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC)
    Karamitopoulou, Eva
    Zlobec, Inti
    Gloor, Beat
    Kondi-Pafiti, Agathi
    Lugli, Alessandro
    Perren, Aurel
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [2] Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC)
    Eva Karamitopoulou
    Inti Zlobec
    Beat Gloor
    Agathi Kondi-Pafiti
    Alessandro Lugli
    Aurel Perren
    Journal of Translational Medicine, 11
  • [3] Loss of Raf-1 kinase inhibitory protein in pancreatic ductal adenocarcinoma
    Kim, Hyun-Soo
    Kim, Gou Young
    Lim, Sung-Jig
    Kim, Youn Wha
    PATHOLOGY, 2010, 42 (07) : 655 - 660
  • [4] Oxysterol-Binding Protein 2 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Epithelial-Mesenchymal Transition
    Huang, Shuai
    Zhang, Xudong
    Luo, Kai
    Jiang, Li
    Jiang, Jianhua
    Li, Renfeng
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [5] Overexpression of Raf-1 kinase inhibitor protein inhibits cell invasion and migration in lung cancer cells through suppressing epithelial-mesenchymal transition
    Wang, Qin
    Li, Xin-Ying
    Wan, Bing
    Zhang, Jie
    Sun, Rong
    Zhou, Chu-Yao
    Zhan, Ping
    Song, Yong
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (06) : 2295 - 2306
  • [6] Trefoil Factor Family 1 (TFF1) Inhibits Epithelial-mesenchymal Transition and Enhances the Chemosensitivity of Pancreatic Ductal Adenocarcinoma (PDAC)
    Yamaguchi, J.
    Kokuryo, T.
    Yokoyama, Y.
    Ebata, T.
    Nagino, M.
    PANCREAS, 2019, 48 (10) : 1551 - 1552
  • [7] NUSAP1 promotes pancreatic ductal adenocarcinoma progression by drives the epithelial-mesenchymal transition and reduces AMPK phosphorylation
    Yuan Liu
    Rong Tang
    Qing-Cai Meng
    Si Shi
    Jin Xu
    Xian-Jun Yu
    Bo Zhang
    Wei Wang
    BMC Cancer, 24
  • [8] NUSAP1 promotes pancreatic ductal adenocarcinoma progression by drives the epithelial-mesenchymal transition and reduces AMPK phosphorylation
    Liu, Yuan
    Tang, Rong
    Meng, Qing-Cai
    Shi, Si
    Xu, Jin
    Yu, Xian-Jun
    Zhang, Bo
    Wang, Wei
    BMC CANCER, 2024, 24 (01)
  • [9] FGFR1 inhibitor reverses Smoothened inhibition-induced epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma
    Chaudhuri, Tista Roy
    Lin, Qingxiang
    Straubinger, Ninfa L.
    Ma, Wen Wee
    Straubinger, Robert M.
    CANCER RESEARCH, 2017, 77
  • [10] Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma
    Ge, Yang
    Liu, Heshu
    Zhang, Yuanyuan
    Liu, Jian
    Yan, Rui
    Xiao, Zeru
    Fan, Xiaona
    Huang, Xuying
    An, Guangyu
    TRANSLATIONAL ONCOLOGY, 2022, 17
12